This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
519972 |
1. Apply sex-specific ruleNone |
519972 |
2. Check conditionsNone |
519972 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
494 |
4. Check minimum number of eventsNone |
494 |
5. Include endpointsNone |
494 |
6. Filter based on genotype QC (FinnGen only) |
485 |
Control definitions (FinnGen only)
- Control exclude
- R18_GENERAL_SYMPTOMS_SIGNS
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF4
- Parent code in ICD-10
- R[5-6]
- Name in latin
- Senilitas
Similar endpoints
↥List of similar endpoints to
Senility
based on the number of shared cases.
Similar with more cases:
- General symptoms and signs
- Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified
- Any event in hilmo or specialist outpatient
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 485 | 261 | 224 |
| Unadjusted period prevalence (%) | 0.10 | 0.09 | 0.10 |
| Median age at first event (years) | 84.29 | 85.17 | 83.26 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 494
- Matched controls
- 4926
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
R54
ICD-10 Finland
Senility
+∞
307.7
494
7
R53
ICD-10 Finland
Malaise and fatigue
15.7
207.4
240
280
R55
ICD-10 Finland
Syncope and collapse
26.1
100.3
72
32
R50.9
ICD-10 Finland
Fever, unspecified
19.8
85.6
69
40
A04
ICPC
Weakness/tiredness general
4.7
44.8
128
343
A28
ICPC
Limited function/disability NOS
3.7
40.5
189
714
R42
ICD-10 Finland
Dizziness and giddiness
3.5
36.4
172
649
N30.0
ICD-10 Finland
Acute cystitis
3.9
35.4
126
393
L28
ICPC
Limited function/disability (L)
3.5
33.2
155
576
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
3.0
31.8
245
1213
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
3.3
29.5
145
552
R56.8
ICD-10 Finland
Other and unspecified convulsions
308.4
29.1
29
*
N05AH04
ATC
quetiapine; oral
3.6
25.7
98
315
F21, ,
ICPC
10.9
25.5
28
27
Z29
ICPC
Social problem NOS
9.4
25.2
31
35
N06AX11
ATC
mirtazapine; oral
2.8
24.1
178
837
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
3.4
23.6
97
327
E86
ICD-10 Finland
Volume depletion
6.4
22.7
39
65
R51.80
ICD-10 Finland
Headache
6.3
22.4
39
66
N05AX08
ATC
risperidone; systemic
3.3
21.8
98
348
A29
ICPC
General symptom/complaint other
3.4
21.1
85
282
N06AB04
ATC
citalopram; systemic
2.7
20.2
137
609
-69
ICPC
Other reason for encounter NEC
5.9
19.8
37
67
N30.9
ICD-10 Finland
Cystitis, unspecified
4.0
18.8
58
160
A23
ICPC
Risk factor NOS
5.1
18.5
40
83
A01
ICPC
Pain general/multiple sites
4.0
17.9
53
142
N05AH03
ATC
olanzapine; systemic
6.6
17.7
29
46
Z03.3
ICD-10 Finland
Observation for suspected nervous system disorder
4.7
17.3
42
96
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
2.6
16.9
114
501
S06.0
ICD-10 Finland
Concussion
3.5
16.9
64
203
W19
ICD-10 Finland
Unspecified fall
3.2
16.8
75
263
A49.9
ICD-10 Finland
Bacterial infection, unspecified
3.0
16.5
81
300
N02AA05
ATC
oxycodone; systemic
2.5
16.4
125
582
J18.9
ICD-10 Finland
Pneumonia, unspecified
2.2
16.3
208
1211
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
2.6
16.2
119
544
N02BE01
ATC
paracetamol; systemic, rectal
2.5
16.1
378
2811
E87.1
ICD-10 Finland
Hypo-osmolality and hyponatraemia
4.5
16.0
41
98
N06DX01
ATC
memantine; oral
2.6
16.0
106
461
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
2.4
15.8
136
668
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
2.2
15.7
201
1168
I95.1
ICD-10 Finland
Orthostatic hypotension
4.3
15.5
42
105
I69.3
ICD-10 Finland
Sequelae of cerebral infarction
2.8
15.2
83
326
P20
ICPC
Memory disturbance
2.5
15.1
118
554
R41.0
ICD-10 Finland
Disorientation, unspecified
4.4
15.1
39
94
F03
ICD-10 Finland
Unspecified dementia
2.7
14.9
91
379
AA1AD
NOMESCO Finland
CT of head and brain
2.3
14.8
140
715
N05BA04
ATC
oxazepam; oral
2.3
14.4
147
775
A06AD11
ATC
lactulose; oral
2.2
14.3
155
836
N03AX16
ATC
[U] pregabalin
2.5
14.1
101
454
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
3.3
13.7
54
175
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
2.5
13.6
95
421
R41.8
ICD-10 Finland
Other and unspecified symptoms and signs involving cognitive functions and awareness
2.8
13.3
72
281
N06AB10
ATC
escitalopram; oral
2.8
13.2
71
276
SPAT1292
SPAT
Other function in accordance with SHToL (Finnish classification of nursing interventions)
2.9
13.1
66
247
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
2.2
12.8
142
769
R07.4
ICD-10 Finland
Chest pain, unspecified
2.2
12.1
122
634
R60.0
ICD-10 Finland
Localized oedema
3.0
12.0
55
195
ZXD10
NOMESCO Finland
Scheduled procedure
2.0
11.8
183
1118
SPAT1222
SPAT
Counselling/guidance promoting independent living
2.3
11.6
97
465
J01MA02
ATC
ciprofloxacin; systemic
2.0
11.6
202
1283
ZXD05
NOMESCO Finland
Urgent procedure
2.0
11.2
151
875
P29
ICPC
Psychological sympt/compl other
5.6
10.9
21
39
N06DA03
ATC
rivastigmine; oral, transdermal
2.8
10.7
55
208
S00.0
ICD-10 Finland
Superficial injury of scalp
5.4
10.6
21
40
I50.9
ICD-10 Finland
Heart failure, unspecified
2.0
10.6
156
929
Z71.8
ICD-10 Finland
Other specified counselling
2.2
10.6
102
518
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
2.0
10.5
161
971
N39.9
ICD-10 Finland
Disorder of urinary system, unspecified
4.8
10.5
24
52
G40.9
ICD-10 Finland
Epilepsy, unspecified
5.1
10.3
22
45
SPAT1137
SPAT
Taking care of patient’s/customer’s hygiene
2.6
10.0
62
258
F05.9
ICD-10 Finland
Delirium, unspecified
4.3
10.0
26
63
Z01.8
ICD-10 Finland
Other specified special examinations
2.3
9.8
80
379
C03CA01
ATC
furosemide; systemic
1.8
9.6
274
1999
N80
ICPC
Head injury other
9.3
9.6
19
21
X59
ICD-10 Finland
Exposure to unspecified factor
2.4
9.5
72
329
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
4.3
9.5
25
61
F32.9
ICD-10 Finland
Depressive episode, unspecified
3.1
9.5
40
135
A99
ICPC
Disease/condition unspecnature/site
2.9
9.4
47
175
I48
ICD-10 Finland
Atrial fibrillation and flutter
1.8
9.4
191
1257
F01.9
ICD-10 Finland
Vascular dementia, unspecified
3.7
9.3
30
85
ZXE10
NOMESCO Finland
More than one and less than three hours
1.9
9.2
160
1001
R63.4
ICD-10 Finland
Abnormal weight loss
7.2
9.1
21
30
U07.1
ICD-10 Finland
Emergency use of U07.1 | COVID-19, virus identified
2.6
9.0
54
221
ZXA00
NOMESCO Finland
Right side
1.9
9.0
141
851
Z51.5
ICD-10 Finland
Palliative care
2.6
9.0
53
215
N03AG01
ATC
valproic acid; systemic, rectal
4.0
8.9
25
64
M79.6
ICD-10 Finland
Pain in limb
1.9
8.9
137
822
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
2.0
8.9
121
697
S01.0
ICD-10 Finland
Open wound of scalp
2.8
8.8
46
175
K90
ICPC
Stroke/cerebrovascular accident
4.2
8.8
23
56
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
2.5
8.7
59
256
F10.1
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Harmful use
4.4
8.7
22
52
N05CF01
ATC
zopiclone; oral
1.8
8.7
196
1323
C07AB07
ATC
bisoprolol; oral
1.8
8.5
263
1939
J01DB01
ATC
cefalexin; oral
1.8
8.5
301
2307
G30.9
ICD-10 Finland
Alzheimer disease, unspecified
2.4
8.5
59
259
D50.9
ICD-10 Finland
Iron deficiency anaemia, unspecified
2.6
8.5
52
215
XF400
NOMESCO Finland
ECG with 12 standard connections
2.1
8.4
92
488
P70
ICPC
Dementia
3.2
8.4
34
112
G30.1
ICD-10 Finland
Alzheimer disease with late onset
2.1
8.4
86
446
R11
ICD-10 Finland
Nausea and vomiting
2.6
8.3
49
199
L97
ICD-10 Finland
Ulcer of lower limb, not elsewhere classified
3.5
8.3
29
87
K22
ICPC
Risk factor cardiovascular disease
3.1
8.2
35
119
R52.9
ICD-10 Finland
Pain, unspecified
3.4
8.2
30
93
U28
ICPC
Limited function/disability (U)
7.4
8.0
18
25
A98
ICPC
Health maint/preventive medicine
1.7
7.9
308
2403
N39.4
ICD-10 Finland
Other specified urinary incontinence
2.5
7.9
52
223
SPAT1216
SPAT
Assessment of functional ability
2.0
7.8
93
508
I25.5
ICD-10 Finland
Ischaemic cardiomyopathy
3.5
7.7
27
81
Z03.89
ICD-10 Finland
Observation for other suspected diseases and conditions
2.5
7.6
48
201
ZY020
NOMESCO Finland
Telephone, letter or other consultation without direct patient contact
3.2
7.5
30
98
I10
ICD-10 Finland
Essential (primary) hypertension
1.7
7.5
304
2383
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
2.6
7.4
45
185
N06AX21
ATC
duloxetine; oral
3.0
7.4
33
115
I63.9
ICD-10 Finland
Cerebral infarction, unspecified
2.0
7.4
94
525
F00.20*G30.8
ICD-10 Finland
Dementia in Alzheimer's disease, atypical or mixed type without additional symptoms
3.2
7.4
29
94
A02BC02
ATC
pantoprazole; systemic
1.7
7.3
256
1924
P28
ICPC
Limited function/disability (P)
+∞
7.3
7
*
N17
ICPC
Vertigo/dizziness
2.3
7.3
57
264
N06CA01
ATC
amitriptyline and psycholeptics; systemic
2.4
7.3
51
225
M54.8
ICD-10 Finland
Other dorsalgia
4.4
7.2
18
42
N05BA06
ATC
lorazepam; systemic, sublingual
2.7
7.2
38
146
M54.9
ICD-10 Finland
Dorsalgia, unspecified
2.5
7.1
46
196
N02AX02
ATC
tramadol; systemic, rectal
1.7
7.0
177
1218
N04BA02
ATC
levodopa and decarboxylase inhibitor; oral
2.8
7.0
34
125
K92.2
ICD-10 Finland
Gastrointestinal haemorrhage, unspecified
3.8
7.0
21
57
A41.5
ICD-10 Finland
Sepsis due to other Gram-negative organisms
3.2
6.9
27
87
SPAT1254
SPAT
Administration of medicine
2.0
6.9
81
440
E000001, ,
ATC
2.0
6.8
80
434
M54.5
ICD-10 Finland
Low back pain
1.9
6.8
103
609
ZX120
NOMESCO Finland
Intravenous
2.5
6.8
43
181
Z46.8
ICD-10 Finland
Fitting and adjustment of other specified devices
4.4
6.8
17
40
A03
ICPC
Fever
2.6
6.7
40
163
K29
ICPC
Cardiovascular sympt/complt other
3.4
6.7
24
73
G04BD12
ATC
mirabegron; oral
2.3
6.7
53
247
WYA30
NOMESCO Finland
Treatment of a patient needing special arrangements
2.6
6.6
39
159
F05.1
ICD-10 Finland
Delirium superimposed on dementia
7.0
6.5
15
22
S20.2
ICD-10 Finland
Contusion of thorax
3.0
6.5
28
96
R5110, ,
SPAT
2.7
6.5
35
136
C08CA01
ATC
amlodipine; oral
1.6
6.3
188
1342
I25.9
ICD-10 Finland
Chronic ischaemic heart disease, unspecified
1.8
6.3
105
639
U04
ICPC
Incontinence urine
2.6
6.3
37
150
J01CA08
ATC
pivmecillinam; oral
1.6
6.3
208
1524
Z02.7
ICD-10 Finland
Issue of medical certificate
2.7
6.2
34
133
S81.8
ICD-10 Finland
Open wound of other parts of lower leg
3.6
6.2
20
57
N06AX26
ATC
vortioxetine; oral
3.6
6.2
20
57
SPAT1156
SPAT
Guidance concerning treatment of rash and skin
2.1
6.1
64
333
K08.3
ICD-10 Finland
Retained dental root
2.8
6.1
30
111
G45.9
ICD-10 Finland
Transient cerebral ischaemic attack, unspecified
2.2
6.1
55
271
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
72
154
5.29
32.54
1.9
1.4
—
—
—
0
0
101
292
4.08
31.26
1.9
1.5
—
—
—
0
0
72
164
4.95
30.19
2.1
1.5
—
—
—
0
0
84
218
4.42
29.96
3.1
3.5
1.44
1.50
mmol/l
0.18
79
207
203
933
2.99
29.75
2.3
2.1
77.85
79.91
nmol/l
0.39
184
787
125
438
3.47
28.99
2.1
1.5
—
—
—
0
0
182
798
3.02
28.90
5.2
3.1
88.00
177.20
e6/l
0.46
146
616
166
703
3.04
27.90
5.0
3.1
0.41
0.75
e6/l
1.53
135
544
97
296
3.82
27.63
2.0
1.5
—
—
—
0
0
193
909
2.83
26.44
4.4
3.1
—
—
—
0
0
107
372
3.38
24.83
4.6
2.8
2.65
3.20
e6/l
0.21
73
204
139
573
2.97
24.08
3.4
2.6
5.40
5.51
e6/l
0.03
127
516
109
393
3.27
23.77
2.1
2.3
9.69
11.41
umol/l
1.72
100
357
220
1159
2.61
23.55
2.6
2.0
86.01
89.69
pmol/l
0.64
129
574
156
714
2.72
21.94
2.7
1.9
177.58
412.65
u/l
1.27
147
653
71
204
3.89
21.82
1.7
1.9
0.18
0.19
g/l
0.31
56
188
104
385
3.15
21.55
4.4
2.7
0.89
1.37
e6/l
1.28
70
215
94
329
3.28
21.38
2.1
2.4
18.53
20.02
%
0.38
88
270
232
1298
2.48
21.31
5.5
4.9
1.22
1.22
mmol/l
0.09
208
1055
148
678
2.68
20.61
1.9
1.5
18.94
20.30
nmol/l
0.44
131
564
208
1122
2.47
20.52
3.5
3.7
32.66
34.21
g/l
2.88
187
1005
152
708
2.65
20.45
2.8
2.1
3.02
3.35
mg/l
0.84
125
593
121
515
2.78
19.33
6.6
3.5
73.90
323.46
ng/l
1.63
115
462
240
1414
2.35
19.03
5.1
3.6
6.82
7.02
mmol/l
0.65
229
1299
215
1213
2.36
18.79
6.7
6.1
4.83
4.42
e9/l
1.46
185
1028
207
1158
2.35
18.35
5.7
4.3
1.22
1.21
mmol/l
0.19
193
1004
226
1337
2.26
17.29
23.4
21.5
1.42
1.49
inr
0.45
70
356
84
314
3.01
16.89
2.2
2.2
0.79
0.82
mmol/l
1.16
75
287
205
1182
2.25
16.52
5.1
4.6
12.36
13.17
umol/l
0.41
199
1094
270
1741
2.21
16.43
8.8
4.9
5823.75
2230.17
e6/l
—
8
46
169
904
2.31
16.25
2.8
2.1
—
—
—
0
0
53
154
3.72
15.92
6.8
3.1
49.93
55.80
ml/min/173m2
1.23
27
69
58
181
3.49
15.66
2.6
1.9
33.88
30.95
u/l
0.44
50
147
36
80
4.76
15.36
1.5
2.0
224.16
1153.51
ug/l
0.93
31
72
173
973
2.19
14.43
3.4
3.1
3142.39
2811.43
ng/l
0.22
145
831
161
906
2.15
13.22
3.5
2.5
134.40
134.30
ug/l
0.00
147
793
264
1808
1.98
12.38
6.9
5.5
92.84
82.96
u/l
1.09
251
1630
27
57
4.94
12.22
1.4
1.3
—
—
—
0
0
27
57
4.94
12.22
1.4
1.3
—
—
—
0
0
111
557
2.27
11.98
3.1
2.7
2.49
2.48
mmol/l
0.44
95
466
33
97
3.56
9.72
1.9
1.4
1.53
0.96
ug/l
0.27
27
79
275
2009
1.82
9.64
26.9
14.9
66.61
65.73
ml/min/173m2
0.28
236
1623
29
79
3.83
9.53
1.4
1.1
—
—
—
0
0
235
1644
1.81
9.45
4.1
3.6
15.87
15.27
pmol/l
2.72
212
1424
41
141
3.07
9.43
1.3
1.5
413.58
406.64
nmol/l
0.06
36
115
258
1862
1.80
9.29
32.8
18.0
15.10
15.53
%
0.79
250
1812
305
2315
1.82
9.26
29.6
14.7
30.45
29.99
mg/l
0.07
286
1888
37
123
3.16
9.00
1.4
1.4
1.49
1.60
g/l
0.24
29
107
38
130
3.07
8.82
3.6
4.9
25.11
25.10
mmol/l
0.00
33
119
66
301
2.37
8.76
2.7
4.2
1.05
1.05
mmol/l
0.06
51
273
48
188
2.71
8.73
1.7
1.5
—
—
—
0
0
274
2036
1.77
8.73
5.3
4.5
2.00
2.12
mu/l
0.69
246
1758
147
912
1.86
8.57
2.8
2.7
2.36
2.36
mmol/l
0.03
123
766
66
308
2.31
8.31
4.0
4.4
104.00
104.02
mmol/l
0.01
66
308
167
1125
1.73
7.17
3.0
2.6
60.49
52.82
u/l
0.35
150
1003
304
2419
1.66
6.75
33.8
18.8
138.84
139.48
mmol/l
2.71
298
2308
304
2425
1.65
6.63
34.0
18.9
3.98
4.02
mmol/l
1.71
298
2309
161
1099
1.68
6.47
5.9
3.8
99.38
65.80
ng/l
0.23
137
834
308
2476
1.64
6.41
38.9
22.4
237.97
239.08
e9/l
0.10
300
2371
308
2477
1.64
6.39
39.0
22.4
4.11
4.30
e12/l
7.56
296
2360
296
2358
1.63
6.38
11.4
8.9
21.95
22.72
u/l
0.22
280
2224
308
2478
1.64
6.37
39.5
22.6
123.16
129.33
g/l
9.40
301
2400
307
2477
1.62
6.20
38.5
22.4
36.74
37.78
%
1.69
294
2212
110
697
1.74
5.73
2.1
1.8
1168.00
1155.81
nmol/l
0.04
82
520
222
1691
1.56
5.49
4.3
3.5
20.40
16.61
mm/h
2.11
198
1501
47
227
2.18
5.45
2.3
2.2
7.78
12.53
umol/l
1.12
41
190
53
272
2.06
5.27
3.0
2.7
247.57
254.13
u/l
0.19
47
257
43
204
2.21
5.21
2.6
2.0
64.74
65.60
g/l
0.34
34
178
57
306
1.97
5.01
3.4
4.5
4.81
5.16
kpa
1.64
50
287
56
303
1.95
4.81
3.5
4.6
0.31
1.56
mmol/l
1.07
44
238
143
1010
1.58
4.80
2.6
2.7
—
—
—
0
0
84
521
1.73
4.67
2.4
2.4
—
—
—
0
0
56
307
1.92
4.63
3.5
4.5
10.67
11.06
kpa
0.25
50
288
57
315
1.91
4.61
1.3
1.2
2.62
1.24
u/ml
0.32
21
84
53
286
1.95
4.59
2.2
3.3
347.83
268.83
ng/l
0.52
46
260
21
76
2.83
4.48
1.6
1.5
36.53
35.50
g/l
0.31
14
66
22
82
2.75
4.45
1.9
2.0
0.67
1.11
g/l
0.29
15
65
22
82
2.75
4.45
2.0
1.7
2.78
3.41
g/l
1.21
15
72
32
145
2.28
4.35
4.2
4.3
2.82
1.97
mmol/l
0.50
18
106
33
152
2.25
4.32
3.8
2.9
0.07
0.29
e6/l
1.36
33
147
161
1199
1.50
4.16
6.9
4.1
0.00
0.00
estimate
-0.00
30
216
160
1191
1.50
4.14
8.2
5.5
0.00
0.00
estimate
-0.00
32
203
49
270
1.90
4.01
3.8
3.6
—
—
—
0
0
160
1203
1.48
3.90
6.8
4.1
0.00
0.00
estimate
-0.00
37
260
28
126
2.29
3.88
1.9
4.2
26.16
24.64
mmol/l
1.10
28
126
22
90
2.50
3.75
2.0
1.6
3.27
3.79
g/l
0.83
15
80
22
90
2.50
3.75
2.0
1.6
—
—
—
0
0
22
90
2.50
3.75
2.0
1.6
6.66
7.96
g/l
1.33
15
80
19
73
2.66
3.66
1.8
1.5
0.00
0.00
g/l
-0.00
13
63
46
263
1.82
3.38
3.6
2.2
4.76
6.13
ug/l
0.46
36
210
9
18
5.06
3.37
1.2
1.3
4.48
3.72
mmol/l
—
9
18
10
23
4.40
3.31
1.2
1.2
542.60
504.96
mg/l
—
10
23
38
206
1.91
3.29
2.0
3.2
79.41
91.62
ng/l
0.50
32
163
68
438
1.64
3.28
1.5
1.5
3.85
1.53
mg/l
0.52
55
331
20
86
2.37
3.10
1.5
1.6
10.45
10.80
g/l
0.11
13
76
63
404
1.64
3.10
2.8
3.4
0.73
0.88
ug/l
0.86
39
281
17
69
2.51
2.97
1.3
1.5
0.00
0.00
g/l
-0.00
12
60
17
69
2.51
2.97
1.1
1.5
0.00
0.00
g/l
-0.00
12
60
246
2076
1.36
2.91
5.7
6.3
41.50
42.02
mmol/mol
0.32
217
1847
47
285
1.71
2.86
2.2
3.4
5.34
7.18
ug/l
0.45
40
240
15
59
2.58
2.79
1.3
1.4
—
—
—
0
0
255
2173
1.35
2.79
4.3
4.8
6.09
6.14
mmol/l
0.20
221
1860
5
6
8.38
2.75
1.0
1.0
—
—
—
0
0
20
93
2.19
2.62
2.5
2.8
3.81
4.25
pmol/l
0.86
15
82
11
38
2.93
2.42
1.4
1.3
—
—
—
0
0
10
33
3.06
2.36
1.0
1.5
—
—
—
0
0
81
587
1.45
2.31
2.9
2.5
33.55
38.24
u/l
0.38
73
563
77
554
1.46
2.28
2.9
2.6
354.34
11366.17
umol/l
3.62
64
456
20
99
2.06
2.27
2.7
1.7
—
—
—
0
0
91
677
1.42
2.26
7.3
4.2
0.00
0.00
estimate
-0.00
31
199
9
29
3.13
2.23
1.9
1.2
—
—
—
0
0
5
10
5.02
2.07
2.0
1.2
—
—
—
0
0
21
111
1.93
2.02
2.7
1.7
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
17
85
2.03
1.91
2.5
2.3
0.30
0.38
u/ml
0.45
11
46
94
724
1.36
1.90
4.9
5.7
14.87
3.71
ug/l
0.59
81
617
230
2004
1.27
1.88
3.8
4.2
1.46
1.46
mmol/l
0.02
190
1743
232
2035
1.26
1.76
3.9
4.3
4.21
4.40
mmol/l
1.88
199
1796
241
2125
1.26
1.74
4.3
4.9
2.33
2.51
mmol/l
2.17
205
1855
5
13
3.86
1.71
6.4
3.5
—
—
—
0
0
75
574
1.36
1.59
3.4
4.8
21.70
22.21
%
0.10
39
312
219
1935
1.23
1.49
3.4
3.8
1.21
1.25
mmol/l
0.39
182
1656
9
43
2.11
1.30
1.2
1.8
—
—
—
0
0
8
41
1.96
1.09
1.6
1.5
—
—
—
0
0
5
22
2.28
1.03
1.0
1.1
—
—
—
0
0
35
256
1.39
1.02
1.3
1.2
61.50
56.37
iu/ml
0.05
12
89
11
61
1.82
0.98
2.7
1.6
—
—
—
0
0
9
51
1.77
0.94
1.2
1.3
—
—
—
0
0
14
85
1.66
0.94
1.7
2.4
—
—
—
0
0
17
109
1.58
0.93
2.1
3.8
1.41
1.53
%
0.44
17
103
81
678
1.23
0.91
1.9
1.8
455.61
10536485.55
pmol/l
0.50
64
541
12
75
1.61
0.74
1.6
1.2
—
—
—
0
0
5
24
2.09
0.74
1.0
1.3
—
2.40
—
0
6
5
25
2.00
0.72
1.0
1.1
—
—
—
0
0
12
76
1.59
0.71
1.6
1.2
—
—
—
0
0
5
26
1.93
0.70
1.0
1.0
—
—
—
0
0
5
26
1.93
0.70
3.8
1.1
—
—
—
0
0
0
23
0.00
0.58
0.0
1.2
—
—
—
0
0
6
39
1.54
0.53
2.7
1.9
—
8.14
—
0
7
12
85
1.42
0.46
1.6
1.3
—
—
—
0
0
13
94
1.39
0.45
1.8
1.9
1.49
1.60
%
—
8
78
69
769
0.88
0.43
3.6
3.5
7.23
12.79
mg/mmol
0.66
45
476
8
57
1.41
0.42
1.0
1.2
—
—
—
0
0
0
15
0.00
0.41
0.0
1.2
—
—
—
0
0
0
16
0.00
0.41
0.0
6.5
—
—
—
0
0
6
45
1.33
0.33
1.2
1.4
—
—
—
0
0
6
46
1.30
0.33
1.8
1.5
—
—
—
0
0
11
86
1.28
0.26
2.5
2.1
8.59
10.27
nmol/l
0.25
11
75
5
40
1.25
0.22
1.8
1.2
—
—
—
0
0
0
10
0.00
0.21
0.0
1.5
—
—
—
0
0
102
966
1.07
0.21
8.0
4.3
—
—
—
0
0
6
48
1.25
0.20
2.3
1.6
—
—
—
0
0
63
593
1.07
0.16
8.4
4.4
1.01
1.01
kg/l
—
7
102
5
63
0.79
0.08
1.0
1.3
—
—
—
0
0
7
68
1.03
0.08
1.0
1.1
—
—
—
0
0
15
162
0.92
0.06
1.6
1.4
—
—
—
0
0
51
497
1.03
0.03
1.5
1.5
1.29
1.28
mmol/l
0.01
44
404
24
247
0.97
0.02
1.5
1.2
40.05
12.12
u/ml
0.34
11
79
33
336
0.98
0.01
12.5
8.6
—
—
—
0
0
28
279
1.00
0.00
4.3
4.6
36.31
32.40
%
0.59
13
166
16
161
0.99
0.00
1.3
1.3
—
—
—
0
0
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
0
9
0.00
0.00
0.0
1.8
—
—
—
0
0
0
9
0.00
0.00
0.0
2.6
—
221.11
—
0
9
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.6
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
166.40
—
0
5
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
2.0
—
15.00
—
0
5
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
13.4
—
14.76
—
0
5
0
7
0.00
-0.00
0.0
1.0
—
103.57
—
0
7
0
8
0.00
-0.00
0.0
1.9
—
1.19
—
0
8
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: R18_SENILITY – Senility
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).